PALO ALTO, Calif., Sept. 16, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced its ProBeam 360° proton therapy system is now available in a multi-room configuration. The ProBeam 360° system is ...
Located in Flint, Mich., the Karmanos Cancer Institute at McLaren Health Care’s Flint Medical Center uses an advanced proton therapy treatment approach to care for cancer patients. Once considered ...
Zach Newbaker, with Boston-based Mevion Medical Systems, works Friday on a proton therapy system, the latest cancer-fighting technology Froedtert & the Medical College of Wisconsin health network is ...
PALO ALTO, Calif. and JINAN, China, May 9, 2019 /PRNewswire/ -- Varian VAR today announced it has signed a strategic cooperation framework agreement with Shandong Cancer Hospital in China, for proton ...
Flash ultra-high dose rate therapy enabled by Varian proton and planning technologies Collaboration between Varian and leading institutions drives progress toward next-generation cancer treatments ...
PALO ALTO, Calif., May 9, 2019 /PRNewswire/ -- Following a comprehensive evaluation by Sykehusbygg HF Norway and regional health authorities, Varian (NYSE: VAR) was selected to equip two proton ...
* Varian Medical Systems Inc - received orders to provide suites of software for national proton therapy centers now being constructed in denmark, u.k. * Varian Medical Systems - confirmed that varian ...
PALO ALTO, Calif., March 17, 2020 /PRNewswire/ -- Varian (NYSE: VAR) announced today, Proton International at UAB has now treated its first cancer patient with the Varian ProBeam ® Compact proton ...
The "United States Proton Therapy Market Report Forecast by Indication. States and Company Analysis 2025-2033" report has been added to ResearchAndMarkets.com's offering. United States Proton Therapy ...
LITTLETON, Mass.--(BUSINESS WIRE)--Mevion Medical System announces that construction is underway for a second proton therapy system at Siteman Cancer Center at Barnes-Jewish Hospital and Washington ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results